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Background: The prevalence rate of eosinophilic esophagitis (EoE) between Japan and Western countries
is quite different. Although multiple factors, including the genetic background, lifestyle and dietary
habits, may account for the difference, the pathogenic mechanism of EoE has not been fully clariﬁed in
Japanese. To elucidate whether EoE's pathogenic mechanisms differ between those populations, we
performed transcriptome analysis of esophageal biopsy specimens from Japanese EoE patients and
compared the identiﬁed gene signatures with published microarray data for EoE patients in the US.
Methods: We prospectively enrolled adult Japanese EoE patients (n ¼ 4) according to the 2011 consensus
guidelines for diagnosis of EoE. Age-matched healthy volunteer subjects (n ¼ 4) were also enrolled as
controls. We assessed the gene expression proﬁles of esophageal biopsies using microarray technology
and then compared the identiﬁed gene signatures with earlier data generated in the US.
Results: Of 42,545 transcripts represented on the microarray, 385 were differentially expressed between
the EoE and control samples (2 fold change and adjusted p-value of <0.05). Our microarray data
showed strong overlapping with the data from US patients with EoE. An EoE-speciﬁc-transcript signature
is typically composed of IL-13-inducible and eosinophil-related genes, including eotaxin-3/CeC che-
mokine ligand 26 (CCL26).
Conclusions: This transcriptome study suggests that the pathogenetic mechanisms of EoE in Japan and
Western countries are similar. Our ﬁndings may contribute to a better understanding of the pathogenesis
of EoE and to more accurate diagnosis of this disease in Japanese individuals.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Eosinophilic gastrointestinal disorders (EGID) are clinicopatho-
logically characterized by massive eosinophilic inﬁltration withinand Immunology, National
, 2-10-1, Okura, Setagaya-ku,
erology and Hepatology, Shi-
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Kinoshita).
ety of Allergology.
rgology. Production and hosting by Elsethe gastrointestinal (GI) tract.1 They are classiﬁed according to the
site of inﬁltration as eosinophilic esophagitis (EoE), gastritis (EG),
gastroenteritis (EGE), enteritis and colitis.2 In Japan, the prevalence
of EoE is reportedly quite low (estimated to be 0.01%),3,4 and much
less than that of EGE.5 In contrast, the prevalence of EoE in Western
countries, including the US and Europe, has been increasing in
recent years, is now estimated to be 0.44e1%6,7 and is much higher
than that of EGE.8 Notably, the prevalence of IgE-mediated food
allergies (except for EGID) is increasing in Japan and shows a similar
tendency to that in Western countries.9,10 Thus, the reason for the
approximate 50e to 100efold difference in the prevalence rates of
EoE between Japan and Western countries is unclear.vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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dietary habits, may account for the difference in EoE between Japan
and Western countries. To date, studies have suggested that EoE is
more common in Caucasians than other racial groups.11,12 Inter-
estingly, EoE may have different clinical presentations and endo-
scopic ﬁndings between racially distinct populations. Moreover,
dietary habits, especially a Mediterranean diet, are reportedly
associated with development of allergic diseases.13 The traditional
diet of Japan is characterized by low fat content, even when
consuming protein and dietary ﬁber, and it tends to prevent in-
ﬂammatory bowel disease and colorectal cancer. In contrast,
Western diets tend to promote those diseases. Since we have
experienced EoE patients in spite of the Japanese genetic back-
ground and traditional Japanese dietary habits, the question arises
as to whether EoE in Japan and Western countries is a different
disease or not. A previous study of the pathogenic mechanism of
EoE analyzed esophageal tissues by the transcriptome approach
and found that eotaxin-3/CeC chemokine ligand 26 (CCL26) played
a crucial role in inducing selective recruitment of eosinophils into
the esophageal epithelium.14
In order to elucidate whether the pathogenic mechanism of EoE
in Japan is similar to that in Western countries, we performed
transcriptome analysis of esophageal biopsy specimens from Jap-
anese EoE patients and compared the identiﬁed gene signatures
with microarray data that have been published for EoE patients in
the US.
Methods
We prospectively enrolled adult Japanese EoE patients (n ¼ 4)
who lived in the countryside and followed a traditional Japanese
lifestyle and dietary habits. After granting informed consent, they
underwent upper GI endoscopy due to their clinical symptoms.
Diagnosis of EoE was deﬁned as >15 eosinophils/HPF persisting in
the distal esophagus even after proton pump inhibitor therapy,
absence of treatment with oral or systemic steroids, in accordance
with the 2011 consensus guidelines,15 and exclusion of other
possible causes of esophageal eosinophilia. Age-matched healthy
volunteer subjects (n ¼ 4) were also enrolled as controls. Control
specimens were deﬁned as having <1 eosinophils/HPF, with no
history of treatment with oral or systemic steroids or EoE. All
esophageal biopsies were obtained from the Department of
Gastroenterology, Shimane University Hospital (Shimane, Japan).Fig. 1. Microarray analysis of differentially expressed genes in esophageal biopsies. The 385 g
with control subjects are shown in a heatmap image. Up-regulated genes are representedThe study was performed according to a protocol approved by the
institutional review board of National Center for Child Health and
Development, Tokyo, Japan. Samples were placed in RNAlater®
solution (QIAGEN, Valencia, CA, USA) at room temperature after
biopsy and then stored at 80 C until gene expression proﬁling.
Microarray analysis (Agilent Technologies, Santa Clara, CA, USA)
was performed according to the manufacturer's instructions.
Brieﬂy, total RNA was extracted with an RNeasy Micro kit (Qiagen)
and then evaluated with an Agilent Bioanalyzer and an RNA 6000
Nano kit (Agilent Technologies). The gene expression proﬁles were
assessed using microarray technology with Agilent SurePrint G3
Human GE 8 x 60k. Data analysis was performed using GeneSpring
software ver. 12.5 (Agilent Technologies). To normalize variation in
the staining intensity between microarrays, the average difference
for all genes on a given microarray was divided by the median of all
measurements on that microarray, and genes in EoE patient spec-
imens that showed a signiﬁcant difference in signal intensity
compared with the same genes in the control specimens (P < 0.05, t
test) were considered to be up-regulated or down-regulated. Hi-
erarchical clustering was performed using the gene expression
data, contrasting the EoE and control specimens (see Fig. 1). The
differentially expressed genes of EoE in Japan and the US were
compared by systematic analysis using the NextBio search engine
(http://www.nextbio.com/b/nextbio.nb)16 (see Fig. 2).
Results
Characteristics of the subjects
The clinical and histopathological characteristics of all subjects
are summarized in Table 1. All patients with EoE had a history of
dysphagia, a common symptom observed among Japanese patients
with EoE.5 The most frequent endoscopic ﬁnding in patients with
EoE was linear furrows, the diagnostic usefulness of which was
recently reported.17 Besides abnormal endoscopic ﬁndings, evi-
dence of marked eosinophilic inﬂammation was observed in all
patients with EoE.
Microarray analysis of differentially expressed genes in esophageal
biopsies
Esophageal biopsy specimens from individual patients were
subjected to whole-genome transcript expression proﬁle analysis.enes differentially expressed (P < 0.05, fold difference  2) in the EoE group compared
in red and down-regulated genes in blue.
Fig. 2. Comparison of gene expression proﬁles in EoE between Japan and the US. NextBio was used to compare our list of dysregulated genes to those of Blanchard et al.,14 using the
same fold difference (2 fold difference). Venn diagrams compare the number of genes identiﬁed as up-regulated and down-regulated in EoE across both datasets.
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differentially expressed (2 fold difference and adjusted p-value of
<0.05) in the Japanese EoE patients versus the normal control bi-
opsy specimens (see Supplementary Table 1). Hierarchical clus-
tering of the signal intensities of the individual transcripts in each
group showed high similarity of transcript expression patterns
among the EoE patients. Of those 385 transcripts, 160 were
expressed more abundantly and 225 were expressed less abun-
dantly in the EoE patients compared with the control group (Fig. 1).
In agreement with a US study of EoE patients,14 cadherin-like 26
(CDH26), pro-melanin-concentrating hormone (PMCH), eotaxin-3/
CCL26, arachidonate-15 lipoxigenase (ALOX15), periostin (POSTN)
and Charcot-Leyden crystals (CLC) were highly up-regulated (>10
fold) genes compared with in the control subjects.
Comparison of gene expression proﬁles in EoE between Japan and
the US
We compared our list of unique up- and down-regulated genes
to that of Blanchard et al. (2006),14 using the same fold difference
(2 fold difference). After removing duplicate genes, expressed
sequence tags and hypothetical genes, both the up- and down-
regulated genes showed correlations between these datasets
(Fig. 2). Fifty-six dysregulated genes were found to overlap between
this study and the US data. Those genes are listed in Table 2.Table 1
Characteristics of the subjects.
Age
(y)
M/F Diagnosis Response to
PPI therapy
Clinical symptoms Endoscopic ﬁ
Dysphagia Heartburn Other
esophageal
symptom
Furrow Con
rin
83 F EoE e þ e e þ e
46 F EoE e þ e e þ e
60 M EoE e þ e e þ þ
43 M EoE e þ e e þ þ
59 M control NA e e e e e
42 M control NA e e e e e
44 M control NA e e e e e
53 F control NA e e e e e
EoE, Eosinophilic Esophagitis; PPI, Proton Pump Inhibitor; NA, Not ApplicableDiscussion
Because the prevalence rates of EoE in Japan and Western
countries are quite different, we compared the gene expression
proﬁles in EoE patients between them. Our microarray data ob-
tained from Japanese EoE patients substantially overlapped with
earlier data from EoE patients in the US,14 suggesting that, even in
different regions and countries with distinct dietary habits, EoE is
the same disease entity.
Our results conﬁrm that an EoE-speciﬁc-transcript signature is
composed of dysregulated genes involved in type-2 inﬂammation,
which plays a central role in the pathogenesis of EoE. Notably, IL-13,
a type-2 cytokine that plays a pivotal role in allergic inﬂammation
and eosinophil-associated tissue remodeling, is known to be
responsible for various types of immune dysregulation.18 Impor-
tantly, our dataset conﬁrmed that IL-13 transcript was sig-
niﬁcantlydalthough the level was quite lowdupregulated in
patients with EoE. In agreement with Blanchard et al.’s report,14 we
identiﬁed eotaxin-3/CCL26, an IL-13-inducible chemokine that
plays a crucial role in inducing selective recruitment of eosinophils
into the esophageal epithelium, as one of the most highly induced
genes in our Japanese EoE tissue biopsy specimens. A number of
other IL-13-inducible genes also exhibited dysregulated expression
in our Japanese patients with EoE. Interestingly, PMCH mRNA, an
appetite-stimulating peptide, was signiﬁcantly upregulated in bothndings Eosinophils Atopic history
centric
g
White
plaque
Stricture Histology
eosinophils/
HPF
Peripheral
blood
eosinophils (/mｌ)
Bronchial asthma
(BA) and/or allergic
rhinitis (RA)
e e 20 122 e
e e >20 NA e
e e >20 169 AR
þ e >50 308 BA, AR
e e <1 NA e
e e <1 NA e
e e <1 NA e
e e <1 NA e
Table 2
Overlapping up- and down-regulated genes in EoE between Japan and the US.
ProbeName Fold difference :
EoE vs control
Gene
symbol
Description
Japan USy
Up-regulated genes
A_23_P502957 26.4 23.4 CDH26 cadherin 26
A_23_P321223 22.5 19.0 PMCH pro-melanin-concentrating hormone
A_23_P215484 22.3 53.2 CCL26 chemokine (C-C motif) ligand 26
A_23_P55373 21.5 20.9 ALOX15 arachidonate 15-lipoxygenase
A_24_P605563 19.7 17.6 IGLJ3 immunoglobulin lambda joining 3
A_33_P3511265 13.4 46.3 POSTN periostin, osteoblast speciﬁc factor
A_23_P101683 12.0 12.7 CLC Charcot-Leyden crystal protein
A_23_P167168 12.0 14.6 IGJ immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides
A_24_P406754 11.7 2.6 LOXL4 lysyl oxidase-like 4
A_32_P315178 10.4 15.0 ATP13A5 ATPase type 13A5
A_33_P3304696 10.0 8.3 IGLV3-21 immunoglobulin lambda variable 3-21
A_24_P240259 8.9 10.9 LRRC31 leucine rich repeat containing 31
A_23_P81898 8.3 14.9 UBD ubiquitin D
A_23_P105144 8.2 6.2 SCUBE2 signal peptide, CUB domain, EGF-like 2
A_23_P140384 6.4 3.6 CTSG cathepsin G
A_23_P321354 5.6 14.0 TMEM71 transmembrane protein 71
A_23_P7212 5.4 5.7 CFI complement factor I
A_23_P18017 4.9 13.1 CPA3 carboxypeptidase A3
A_23_P1904 4.8 4.2 MS4A2 membrane-spanning 4-domains, subfamily A, member 2
A_23_P117662 4.7 3.1 HDC histidine decarboxylase
A_24_P263786 4.1 6.1 IGKC immunoglobulin kappa constant
A_23_P330070 4.1 5.1 TFPI tissue factor pathway inhibitor
A_23_P1552 3.9 9.0 CTSC cathepsin C
A_23_P169092 3.7 4.3 CYP7B1 cytochrome P450, family 7, subfamily B, polypeptide 1
A_33_P3405728 3.3 5.3 PKP2 plakophilin 2
A_33_P3322804 3.2 7.4 NTRK2 neurotrophic tyrosine kinase, receptor, type 2
A_24_P3249 3.2 2.2 RARB retinoic acid receptor, beta
A_23_P135548 3.1 3.4 DPYD dihydropyrimidine dehydrogenase
A_33_P3373775 3.1 9.7 BCL2L15 BCL2-like 15
A_24_P157370 3.0 3.4 IL17RB interleukin 17 receptor B
A_24_P419300 3.0 8.1 PP7080 uncharacterized LOC25845
A_33_P3224819 3.0 3.1 SLC45A4 solute carrier family 45, member 4
A_33_P3364268 2.9 3.1 LBH limb bud and heart development homolog
A_24_P161018 2.8 2.3 PARP14 poly (ADP-ribose) polymerase family, member 14
A_23_P10506 2.7 5.3 HPGDS hematopoietic prostaglandin D synthase
A_23_P27606 2.6 3.3 IL27RA interleukin 27 receptor, alpha
A_24_P397489 2.6 2.9 GCNT2 glucosaminyl (N-acetyl) transferase 2, I-branching enzyme
A_24_P133253 2.5 3.9 KITLG KIT ligand
A_23_P3532 2.5 3.6 LITAF lipopolysaccharide-induced TNF factor
A_23_P121527 2.5 2.5 KLHL5 kelch-like 5
A_23_P144096 2.4 3.2 CISH cytokine inducible SH2-containing protein
A_33_P3245908 2.4 2.2 C10orf128 chromosome 10 open reading frame 128
A_32_P53524 2.3 2.6 NTN1 netrin 1
A_23_P42718 2.2 2.9 NFE2L3 nuclear factor (erythroid-derived 2)-like 3
A_24_P408736 2.2 2.4 GALNT5 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5
A_33_P3410093 2.2 2.2 LTA4H leukotriene A4 hydrolase
A_33_P3342528 2.1 2.4 P2RY1 purinergic receptor P2Y, G-protein coupled, 1
A_23_P30655 2.0 2.1 NFKBIE nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
Down-regulated genes
A_24_P206776 4.1 6.3 CRYAB crystallin, alpha B
A_33_P3293958 3.8 2.8 TUBB2A tubulin, beta 2A class IIa
A_23_P69810 3.0 4.7 AGPAT9 1-acylglycerol-3-phosphate O-acyltransferase 9
A_23_P4536 2.4 14.6 EPB41L3 erythrocyte membrane protein band 4.1-like 3
A_24_P46130 2.3 5.0 ACPP acid phosphatase, prostate
A_24_P152968 2.1 3.9 AKR1C1 aldo-keto reductase family 1, member C1
A_33_P3265030 2.1 2.4 GP1BB glycoprotein Ib (platelet), beta polypeptide
A_33_P3231252 2.1 3.0 NHLH2 nescient helix loop helix 2
y US data: Previously reported by Blanchard et al.14
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known. We previously reported that PMCH was the most strongly
induced gene (over 1200-fold up-regulation) in the human vascular
endothelial cell transcriptome in response to such type-2 cytokines
as IL-4 and IL-13, in a STAT6-dependentmanner.19 Since PMCH is an
endothelial, but not an epithelial, cell-speciﬁc transcript, over-
expression of PMCH may imply that an IL-13-mediated inﬂamma-
tory response might extend to esophageal endothelial cells, in partbecause of esophageal epithelial barrier dysfunction. Greater un-
derstanding of the pathophysiological roles of MCH in EoE patients
may lead to serumMCH becoming a useful surrogate biomarker for
IL-13 in EoE patients.
Our microarray data also showed that a number of eosinophil-
speciﬁc genes were dramatically upregulated in EoE patients,
including CLC (12 fold), ALOX15 (21 fold) and CeC chemokine re-
ceptor type 3 (CCR3) (3.5 fold). CLC likely promotes
T. Shoda et al. / Allergology International 64 (2015) 260e265264proinﬂammatory changes, including epithelial hyperplasia, and it
correlates with mucosal inﬂammation in EoE.20 Matoso et al.
recently reported that ALOX15 may be a useful diagnostic marker
for EoE.21 CCR3 is known to contribute to accumulation and acti-
vation of eosinophils, and it binds and responds to eotaxin-3/
CCL26.14 Furthermore, Transforming growth factor (TGF) -b1 pro-
duced by eosinophils is responsible for overexpression of various
molecules involved in the tissue remodeling process. Notably,
periostin, a matricellular protein, is known to be critically involved
in the pathogenesis of allergic diseases,22 not only as a component
in subepithelial ﬁbrosis but also by playing a key role in the
ampliﬁcation and chronic nature of allergic skin inﬂammation.23
We previously reported that both IL-13 and TGF-b1 play a role in
inducing periostin production by subepithelial cells, including
endothelial cells, in a corticosteroid-insensitive manner.24 Indeed,
periostin expression remains increased in corticosteroid-treated
patients with EoE.25 The genes identiﬁed in this study were also
identiﬁed byWen et al.,26 using an EoE diagnostic panel based on a
96-gene expression proﬁle. These observations further support our
present ﬁndings suggesting that EoE in both Japan and Western
countries should be considered to be the same disease entity.
The ﬁndings of our dataset conﬁrmed almost exactly the ﬁnd-
ings of the earlier EoE dataset from the US. There were small dis-
crepancies, probably due in part to the use of different microarray
platforms in the studies. For instance, a recent genome-wide as-
sociation study by Kottyan et al. showed that calpain 14 (CAPN14) is
closely associatedwith EoE.27 It was also identiﬁed as a signiﬁcantly
increased gene in our Japanese EoE patients, but not in Blanchard's
study. On the other hand, ﬁlaggrin (FLG), which might disrupt
normal esophageal barrier function,28 was identiﬁed as a signiﬁ-
cantly decreased gene in Blanchard's dataset, but not in our study.
Despite recent evidence showing that thymic stromal lympho-
poietin (TSLP) plays a crucial role in the pathogenesis of EoE,18 TSLP
expressionwas not signiﬁcantly increased in our EoE patients when
compared with the healthy control subjects, as in Blanchard et al.’s
study.14
Several mechanisms might explain the regional differences in
prevalence of EoE. The reported low prevalence of EoE in Japan
might be due not only to a lack of awareness of this illness but also
different genetic and environmental factors between Japan and
Western countries. EoE was recently recognized as a form of food
allergy.2 Although Japanese dietary habits, which have been
different from those of Westerners for a long time, might be asso-
ciated with the low prevalence of EoE in Japan, our data suggest
that the mechanism underlying the pathogenesis of EoE is similar.
In that scenario, once disease develops, dietary habits would no
longer play any role in the progression of EoE. Currently, EGE is
more prevalent than EoE in Japan, from children to adults.5,29
Application of our microarray analysis to the entire GI tract might
lead to elucidation of the precise mechanisms of EGID, and more
studies are clearly warranted.
In conclusion, this transcriptome study suggests that the path-
ogenetic mechanisms of EoE in Japan and Western countries are
similar. Our ﬁndings may contribute to a better understanding of
the pathogenesis of EoE and to more accurate diagnosis of this
disease in Japanese individuals.
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